PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cell Lung Cancer

Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer

March 29, 2021

AstraZeneca Signs an Agreement with ArcherDX for Utilizing Personalized Cancer Assays to Detect MRD in Patients with Early-Stage Non-Small Cell Lung Cancer

AstraZeneca Signs an Agreement with ArcherDX for Utilizing Personalized Cancer Assays to Detect MRD in Patients with Early-Stage N...

May 26, 2020

Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

May 19, 2020

Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Breakthrough Therapy Designation for HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Breakthrough Therapy Designation f...

May 18, 2020

Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20

Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20

May 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us